Suki offers Suki Assistant, a generative-AI clinical assistant that ambiently listens to patient‑clinician conversations to create documentation, assist with coding, answer medical questions, and retrieve chart data. The company also licenses Suki Platform to partners who want to add ambient and voice AI capabilities to their products. Suki reports usage at 350 health systems and clinics and says clinicians complete notes 72% faster on average; the company claims a 9X ROI in year one for organizations. In 2024 Suki expanded 4x in 12 months and has been scaling technology, partnerships, and headcount to support further growth. Recent platform partnerships include Zoom (Workplace for Clinicians) and Google Cloud (Vertex AI integration) to add patient summaries, Q&A, and other features that speed clinical decision‑making. The company has added senior hires in marketing, legal, and infrastructure as part of this growth phase. Suki is positioned to deepen integrations with major EHR and healthcare technology partners such as Epic, athenahealth, MEDITECH, and others. Suki builds AI voice solutions for healthcare, notably Suki Assistant—an ambient, generative‑AI clinical documentation assistant—and Suki Platform, a suite of developer tools for embedding AI and voice into healthtech products. Suki Assistant ambiently generates notes, supports dictation and commands, simplifies coding, retrieves live EHR chart data, and incorporates vitals and pre‑charting into notes. The company reports industry‑leading metrics: 70+ percent clinician adoption, note completion up to 72% faster, and a reported 9X ROI in year one. Suki has expanded partnerships with major EHRs and health systems, including Epic, Oracle Cerner, MEDITECH, Athena, MedStar Health and more than a dozen major health systems and hospitals recently. The company will use the new capital to invest in commercial initiatives, accelerate product development, expand its leadership team, and broaden offerings beyond its existing Assistant and Platform products. Suki says its products augment clinician workflows, improve documentation quality and clinician well‑being, and enhance revenue capture for health systems. Suki.AI develops Suki Assistant, a voice-enabled digital assistant, and the Suki Speech Platform, using natural language processing and machine learning to generate clinically accurate medical notes and retrieve patient information from electronic health records. The company supports physicians across specialties including cardiology, orthopaedics, plastic surgery, ophthalmology, pediatrics and family medicine. Suki claims to reduce documentation time by 76% on average. The fresh funding will be used for strategic investments to advance the AI capabilities of its assistant and speech platform and to add features that streamline documentation, coding and other administrative tasks. Suki reported that it quadrupled its revenue in the last year. The company was founded in 2017 by Punit Singh Soni, who is the CEO.

Total raised

$125M

Funding rounds

3

Latest round

Series D

Latest activity

Oct 2024